polyangiitis (MPA) (ANCA-associated vasculitis). Th-associated cytokines occur at low concentrations in plasma, while chemokine responses commonly are 10-to 50-fold more intense than those of cytokines (3) . Moreover, chemokines are strongly linked to different Thsubsets since they are induced by key cytokines (IFN-, IL-4/IL-13, IL-17) in order to recruit respective Th subset (4) (5) (6) (7) (8) and they have proven useful as markers of Th1, Th2 and Th17-associated diseases (3, 4, 9) . In the present study we assessed chemokines and cytokines representative of Th1-, Th2-, and Th17-like immunity in patients with GPA or MPA.
Two separate cohorts of patients with GPA or MPA (10) were included (Table 1a and 1b).
Cohort I was compared to 19 healthy controls (mean age 65 years, 60% men). After subsequent re-analyse of these samples they were added to 19 new controls (mean age 58 years, 37% men) and compared to cohort II. The study was approved by the regional ethics committee.
EDTA plasma were stored in -70 o C. Milliplex Human MAP Cytokine/Chemokine Panel (Millipore, Billerica, MA, USA) was used to measure (lowest detection limit in brackets): Th1;
IFN- (3.2 pg/ml) and CXCL10 16 pg/ml), Th2; IL-13 (3.2 pg/ml) and CCL22 (80 pg/ml),
Th17
; IL-17A, in the following termed IL-17 (1.6 pg/ml), IL-23 (p19/p40) (49 pg/ml), CCL20
(10 pg/ml) and CXCL1 (16 pg/ml). Due to low detectability IL-23 was only analysed in cohort I.
CXCL10-levels (Th1) were higher in remission than in controls in the larger cohort II, but not in cohort I (Figure 1a ). Both cohorts showed lower levels of Th2-associated CCL22 in active vasculitis, both compared to controls and to patients in remission (Fig 1b) . CCL20-levels (Th17) were increased in active vasculitis compared to controls in both cohorts and possibly also compared to patients in remission (tendency in cohort I, significant in cohort II) ( Figure 1c ). CXCL1-levels (Th17) were higher in remission compared to controls in the larger cohort II, while this was not seen in cohort I ( Figure 1d ). All findings in cohort II were confirmed when all patients (both cohorts) were analysed together, and no new significant findings appeared.
In contrast to chemokines, cytokine levels representing Th1 (IFN-, Th2 (IL-13) and Th17 (IL-17 and IL-23) did not differ between the groups. The detectability of cytokines varied (78%, 44%, 90%, 39% of patient samples were above the detection level for IFN, IL-13, IL-17 and IL-23, respectively). Conversely, CXCL10, CCL22, CXCL1 were detectede in all samples, while CCL20 was detected in only 3% of controls, in 32% of remission, and in 58% of active diseases-samples (Chi-square p<0.001 in both cohorts).
Disease activity (BVAS) correlated negatively with plasma levels of CCL22 in both cohorts (Spearman rank r = -0.618, p=0.0001 and r= -0.311, p=0.006, respectively), and positively with CCL20 in both cohorts (r = 0.362, p=0.038 and r=0.279, p=0.015, respectively). Similar negative correlations to CCL22 and positive correlations to CCL20 were also found for plasma levels of CRP and prednisolone dose. Plasma creatinine and CXCL10 correlated weakly in cohort II (r=0.263, p=0.022) but not in cohort I. No other correlations were found between disease-associated parameters and cytokines/chemokines.
Thus, by using two cohorts of patients, we demonstrated increased plasma levels of CCL20 and CXCL1 and decreased CCL22-levels, indicating a disbalance in Th-associated chemokines in ANCA-associated vasculitis. The increase in CCL20 and CXCL1 is in line with previous reports on increased Th17-associated activity (1,2), here extended to involve chemokines as Th17-markers. The decrease in Th2-associated CCL22 is new and points to a dysbalance also in the Th1/Th2-axis. The main findings were consistent across the cohorts, although cohort I revealed fewer aberrations in the remission group, which is likely due to the smaller sample size and the pre-dominance of patients with long-standing remission.
Our study confirms that chemokines, in contrast to cytokines, are readily detected in plasma (3) . The finding that deviations of Th17 and Th2-chemokines occurred or were most pronounced in active disease, as well as the associations with disease activity and CRP for both CCL20 and CCL22, indicate that these chemokines could be useful as biomarkers of disease activity. However, a longitudinal study design is needed to make any conclusions regarding the predictive value of chemokines in vasculitis. Fig 1a) , CCL22
(reflecting Th2, Fig 1b) , and Th17-associated CCL20 (Fig 1c) , CXCL1 (Fig 1d) , and IL17A (Fig 1e) . The figures show the results from cohort I and cohort II subdivided into the groups of active vasculitis, remission, and controls. Differences between groups were first tested with Kruskal Wallis test and if p<0.05 subsequently with Mann-Whitney´s test. Values below the detection limit were given a value of half the detection limit, corresponding to half the value of the lowest standard point. 
